Member Info for icalvert

C7

May the random variables be with you!

RuckRover

Maybe not a baby elephant maybe more like a Cartwheel coin or maybe not?

I guess the trial will clearly be a major success by Christmas?

Last October the French sent an army to Nottingham to attempt to steal Moditope.
They were met with fierce resistance .... including a young Ken Clarke??

Wicked!

In the tragic event of a no withdrawal agreement and a Brexit in April, maybe Scancell should pre-empt an AIM crash with a positive RNS inspired by BlackAdder Goes Forth?... after Baldrick.

Chelsea,

Thanks for this. I hope and trust history will judge Gottlieb kindly.

Maybe, Baldrick question 3, Scott Gottlieb be judged as a Captain Blackadder in the Trump administration?

Baldric Question 2,

Why doesn't the BOD issue an RNS saying they know of no reason for today's 15% fall except possibly the future of City Financials 21m shares?

At the risk of asking a Baldrick war question.

I guess this is a 100 participant/patient Phase 1 trial which started last year of a combination of a checkpoint inhibitor with PF-06936308, does anyone here or outsider Pfizer know what is the history PF-06936308 ? and ….. does the vaccination hurt?

I think the share price could now reasonably be nearer 150p than 100p.

Three years ago the general perception of Egyptian political risk was arguably worse: President El--Sisi had only been in power since June 2014 and.... Egyptian football had no world class players?

However the Egyptian legal system is still even slower than the UK parliament/government.

Optimism from RetiredBanker, whatever next?

Maybe detailed numerical concerns about upping production from POX or processing others' gold?

Maybe POG should provide RNS updates on those two relatively new concerns throughout 2019?

Knowlesi

I have just looked at the Ichor website for anything about FDA delays: it was disappointing.

Unless good news is imminent, and anyway by (say) 29 March I think our BOD, should provide an, ideally RNS, update about about timing of the SCIB1+ Keytruda , UK+ USA, trial.

Is there any current information about who is holding the convertibles?

I do hope it is not Kansas City Dentists , from an earlier generation.

I agree probably with CofE that this is a buy at 8.16p

Three months after the last update, when would it be reasonable to expect another update including on Scancell management current thinking on ICHOR and USA trials?

As a positive long term holder , with a loss of £10k here, I look forward to quarterly reports which not only itemise growing , POG and possibly other, POX production but also include some estimates of POX production profitability in view of debts.

D'oh!

A RNS on financing plans for Project Bblueprint might well follow shortly. Lindy is usually right about such things as Project Blueprint.

I read on this board that the GC results will be announced at midnight. Is that correct?

In view of yesterday's RNS information , today's SP behaviour and Simpsonsic business principles I bought a few more today

D'oh

Thanks Wildforce.

The one i received late yesterday included:

Whereas Professor Jack Cuzick, an expert in cancer prevention, is particularly excited about building the evidence that might lead to low-dose aspirin being recommended “as a means of preventing cancer”.

Aside from a scientific curiosity about the causal mechanism, my initial reaction was "you cannot be serious".

Please can someone knowledgeable give a scholarly view or simple reference.

Is it wise to expect 2019 guidance, including POX plans (including estimated costs), by the end of January?

Great, TorquayFan

Intriguingly the cancer letter is dated July 2017. Maybe there should be a CRUK update after the January 2019 results?

Ben18

As a lth of POG I was content with ICBC as bankers to IRC, perhaps the appropriate diplomatic description of Gazprombank is well connected ?

Alas IRC will never be a Champions League risk!

Happy Christmas everyone.